Template:Hormone levels with oral estradiol valerate
Jump to navigation
Jump to search
Template documentation
- Hormone levels with oral estradiol valerate
See also
References
- ↑ Jensen, Jeffrey; Bitzer, Johannes; Serrani, Marco (2013). "Comparison of the pharmacologic and clinical profiles of new combined oral contraceptives containing estradiol". Open Access Journal of Contraception: 39. doi:10.2147/OAJC.S50693. ISSN 1179-1527.
- ↑ 2.0 2.1 Timmer CJ, Geurts TB (1999). "Bioequivalence assessment of three different estradiol formulations in postmenopausal women in an open, randomized, single-dose, 3-way cross-over study". Eur J Drug Metab Pharmacokinet. 24 (1): 47–53. doi:10.1007/BF03190010. PMID 10412891.
- ↑ 3.0 3.1 Wiegratz I, Fink T, Rohr UD, Lang E, Leukel P, Kuhl H (September 2001). "Überkreuz-Vergleich der Pharmakokinetik von Estradiol unter der Hormonsubstitution mit Estradiolvalerat oder mikronisiertem Estradiol" [Cross-over comparison of the pharmacokinetics of estradiol during hormone replacement therapy with estradiol valerate or micronized estradiol]. Zentralbl Gynakol (in German). 123 (9): 505–12. doi:10.1055/s-2001-18223. PMID 11709743.
| Editors can experiment in this template's sandbox (create | mirror) and testcases (create) pages. Subpages of this template. |